2009年11月中国医药分销行业研究报告

相似文件 换一批

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

【出版时间及名称】：2009年11月中国医药分销行业研究报告
        【作者】：摩根斯坦利
        【文件格式】：PDF
        【页数】：88
        【目录或简介】：
Contents
Investment Case............................................................................................................................................................. 3
Drug Distribution – A Long-Term Growth Industry .................................................................................................................................................. 3
Government Support is Boosting Growth................................................................................................................................................................ 3
Industry Consolidation Could Offer Further Upside................................................................................................................................................. 3
EDL Makes the Biggest Even Bigger ...................................................................................................................................................................... 3
Drug Distribution Industry Overview ............................................................................................................................ 4
Planned Economy Stage (1950–1984) ................................................................................................................................................................... 4
Transitioning Stage (1985–1989) ............................................................................................................................................................................ 4
Market-oriented Stage (1990–present) ................................................................................................................................................................... 5
Current Industry Landscape ......................................................................................................................................... 5
Pharmaceutical Sales in China ..................................................................................................................................... 6
Major Challenges of the Drug Distribution Industry.................................................................................................... 7
Future Trends: The Impact of Healthcare Reform ....................................................................................................... 8
Industry Regulations and Policies ............................................................................................................................... 9
Competitive Analysis ................................................................................................................................................... 10
Industry Players ........................................................................................................................................................... 12
Drug Distributors: Financial Comparisons................................................................................................................. 23
Company Analysis
Sinopharm Group: China Healthcare Proxy with Robust Growth but Upside Priced in for Now; Initiate EW .............. 27
Company Background
Overview ....................................................................................................................................................................... 66
Change in Shareholder Structure............................................................................................................................... 66
Pharmaceutical Distribution: Products & Services ................................................................................................... 72
Retail Business: A Meaningful Presence in China .................................................................................................... 76
Other Business Operations......................................................................................................................................... 76
Business Strategies – Organic Growth Complemented by M&A............................................................................. 77
Case Study: How did Sinopharm grow Organically and through Acquisitions? ................................................... 78

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏0 回帖

关键词：行业研究报告 中国医药 研究报告 行业研究 distribution 研究报告 行业 分销 中国医药

天价……
呜呜……
便宜点啊……
那么多0

你已经非常富有了

为什么卖这么贵，真没有诚意！！

太贵了，怎么分享啊。

夸张了点。。。

能不能给我发一份呢ycl-0536@163.com。谢谢了

哥，这也太贵了吧……

这个 不是 一般能买的了的 LZ方便的话 发到我邮箱一份 可以吗？yuchixiaolan@gmail.com
以后有好的资料必定与你交流

Million Thanks!

买不起啊 建议楼主打个折卖了